PARP1 and cancer: Although there is much to be further explored, here we demonstrate for the first time that STAT1 might act at both transcriptional and post-transcriptional levels to modulate the PARP1 level in HGSOC, suggesting new pathways to be exploited for targeting cancer cells, based on their dependency on PARP1.